Stay updated on PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Sign up to get notified when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.

Latest updates to the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed description of a Phase 3 clinical trial for PH94B nasal spray aimed at treating social anxiety disorder. The only notable addition is the mention of the revision number, which does not alter the core information.SummaryDifference42%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.